However, host obesity is associated with heightened immunotherapy resistance, characterized by multi-factorial deficiencies in effector CD4+ and CD8+ T cell responses that extend beyond the tumor microenvironment. This evidence concerns the gene CD4 and obesity due to melanocortin 4 receptor deficiency.